CORDOVA ASHLEY (Chief Financial Officer) received a stock award from NOVOCURE LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001822014-26-000002
Officer· Chief Financial Officer
Since Sep 2020
+2.64K
Net shares
Net buyer
$290.4K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
23.82K acquired · 21.18K disposed
Non-Derivative Transactions4
Ordinary Shares
Direct
Shares
−11.54K
Price / share
$13.75
Trade value
$158.69K
% of position
2.6%
2/27/2026
437.57K→426.03K
Ordinary Shares
Direct
Shares
+23.82K
Price / share
—
Trade value
—
% of position
5.6%
2/28/2026
426.03K→449.85K
Ordinary Shares
Direct
Shares
−2.41K
Price / share
$13.67
Trade value
$32.94K
% of position
0.5%
3/2/2026
449.85K→447.44K
Ordinary Shares
Direct
Shares
−7.23K
Price / share
$13.67
Trade value
$98.81K
% of position
1.6%
3/2/2026
447.44K→440.21K
Total
Net shares
+2.64K
Net value
-$290.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/27/2026 | F · Tax Withholding | −11.54K | $13.75 | $158.69K | 2.6% | 437.57K | 426.03K |
| Ordinary Shares Direct | 2/28/2026 | A · Award | +23.82K | — | — | 5.6% | 426.03K | 449.85K |
| Ordinary Shares Direct | 3/2/2026 | F · Tax Withholding | −2.41K | $13.67 | $32.94K | 0.5% | 449.85K | 447.44K |
| Ordinary Shares Direct | 3/2/2026 | F · Tax Withholding | −7.23K | $13.67 | $98.81K | 1.6% | 447.44K | 440.21K |
| Total | +2.64K | -$290.44K | ||||||
Derivative Transactions0
No derivative transactions reported